Company No:
Contents
| Note | 2024 | 2023 | ||
| £ | £ | |||
| Fixed assets | ||||
| Intangible assets | 3 |
|
|
|
| Tangible assets | 4 |
|
|
|
| 4,979 | 3,392 | |||
| Current assets | ||||
| Debtors | 5 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 4,552 | 2,883 | |||
| Creditors: amounts falling due within one year | 6 | (
|
(
|
|
| Net current (liabilities)/assets | (2,618) | 733 | ||
| Total assets less current liabilities | 2,361 | 4,125 | ||
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital |
|
|
||
| Profit and loss account |
|
|
||
| Total shareholder's funds |
|
|
Director's responsibilities:
The financial statements of Shafiq-Ali R Pradhan Ltd (registered number:
|
Dr Shafiq-Ali Pradhan
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.
Shafiq-Ali R Pradhan Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is High Street Surgery & Medical Centre, 301 High Street, Epping, CM16 4DA, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
The company's previous financial statements were prepared from incorporation on 7 November 2022 to 30 November 2023. The financial statements are therefore not entirely comparable.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.
| Website costs |
|
| Office equipment |
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Income Statement as described below.
| 2024 | 2023 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including the director |
|
|
| Website costs | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 December 2023 |
|
|
|
| Additions |
|
|
|
| At 30 November 2024 |
|
|
|
| Accumulated amortisation | |||
| At 01 December 2023 |
|
|
|
| Charge for the financial year |
|
|
|
| At 30 November 2024 |
|
|
|
| Net book value | |||
| At 30 November 2024 |
|
|
|
| At 30 November 2023 |
|
|
| Office equipment | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 December 2023 |
|
|
|
| Additions |
|
|
|
| At 30 November 2024 |
|
|
|
| Accumulated depreciation | |||
| At 01 December 2023 |
|
|
|
| Charge for the financial year |
|
|
|
| At 30 November 2024 |
|
|
|
| Net book value | |||
| At 30 November 2024 | 3,780 | 3,780 | |
| At 30 November 2023 | 3,392 | 3,392 |
| 2024 | 2023 | ||
| £ | £ | ||
| Trade debtors |
|
|
|
| Prepayments |
|
|
|
|
|
|
| 2024 | 2023 | ||
| £ | £ | ||
| Trade creditors |
|
|
|
| Amounts owed to director |
|
|
|
| Accruals |
|
|
|
| Corporation tax |
|
|
|
| Other creditors |
|
|
|
|
|
|